|
| The item of major registration documents | Classic Chinese medicine formulation (China) | Standard formulation of Chinese medicine (Taiwan) | Established medicine (Hong Kong) | Kampo medicine (Japan) | Herbal drug (Korea) |
|
(1) General documents | (1.1) Origin or background of discovery, conditions of use in foreign countries | × | × | × | × | ⃝ |
(1.2) The therapeutic group, comparisons with other drugs, and related information | × | × | × | ⃝ | ⃝ |
|
(2) Product quality documents | (2.1) Quality data on crude drugs | | | | | |
(2.1.1) The production information of crude drugs | ⃝ | × | × | × | × |
(2.1.2) The resource evaluation of crude drugs | ⃝ | × | × | × | × |
(2.1.3) Quality standards study data of crude drugs | ⃝ | × | × | × | ⃝ |
(2.1.4) Quality standards | ⃝ | × | ⃝ | × | ⃝ |
(2.1.5) Test report | ⃝ | × | ⃝ | × | ⃝ |
(2.2) Quality data on prepared slices of crude drug | | | | | |
(2.2.1) Processing information | ⃝ | × | × | × | × |
(2.2.2) Quality standards study data of crude drugs | ⃝ | × | × | × | × |
(2.2.3) Quality standards | ⃝ | × | × | × | × |
(2.2.4) Test report | ⃝ | × | × | × | × |
(2.3) Quality data on corresponding objects of substance benchmark | ⃝ | × | × | × | × |
(2.4) Manufacturing method data of the product | | | | | |
(2.4.1) Study data on manufacturing method in each step | ⃝ | × | × | × | ⃝ |
(2.4.2) Manufacturing verification or recorded data | ⃝ | ⃝ | × | × | × |
(2.4.3) Description of manufacturing method | ⃝ | ⃝ | ⃝ | × | ⃝ |
(2.5) Quality data on product | | | | | |
(2.5.1) Quality standards study data | ⃝ | △ | × | ⃝ | ⃝ |
(2.5.2) Quality standards | ⃝ | ⃝ | ⃝ | ⃝ | ⃝ |
(2.5.3) Test report | ⃝ | ⃝ | ⃝ | ⃝ | ⃝ |
(2.6) Stability test report | ⃝ | ⃝ | ⃝ | △ | ⃝ |
(2.7) Data for container and packaging material | ⃝ | × | × | × | ⃝ |
|
(3) Product safety documents | (3.1) Acute, subacute, and chronic toxicity, teratogenicity, and another type of toxicity | | | | | |
(3.1.1) Single-dose toxicity test report | ⃝ | × | ⃝ | × | ⃝ |
(3.1.2) Repeated-dose toxicity test report | ⃝ | × | ⃝ | × | △ |
(3.1.3) Genotoxicity test report | × | × | × | × | × |
(3.1.4) Local irritation test report | × | × | ⃝ | × | △ |
(3.1.5) Carcinogenicity test report | △ | × | × | × | × |
(3.1.6) Reproductive toxicity test report | △ | × | × | × | × |
(3.1.7) Other toxicity tests | × | × | × | × | × |
(4) Product efficacy documents | (4.1) Reference materials on product efficacy | ⃝ | × | ⃝ | × | × |
(4.2) Absorption, distribution, metabolism, and excretion study | × | × | × | × | × |
(4.3) Pharmacodynamic study (primary and secondary) | × | × | × | × | × |
(4.4) Pharmacological study | × | × | × | × | × |
(4.5) Clinical trial report | × | × | × | × | × |
|